Walleye Trading LLC Fate Therapeutics Inc Call Options Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$9.86 - $23.83 $16,762 - $40,511	-1,700 Reduced 9.5%	16,200 $163,000
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $90,472 - $155,058	4,300 Added 31.62%	17,900 $401,000
Q2 2022 Aug 08, 2022	BUY	$17.78 - $42.39 $83,566 - $199,233	4,700 Added 52.81%	13,600 $337,000
Q1 2022 May 16, 2022	BUY	$29.67 - $60.28 $32,637 - $66,308	1,100 Added 14.1%	8,900 $345,000
Q4 2021 Feb 14, 2022	BUY	$47.84 - $64.34 $373,152 - $501,852	7,800 New	7,800 $456,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $222M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.